ProCE Banner Activity

Improving Outcomes With New Therapies for Patients With Acute Myeloid Leukemia

Slideset Download
The recent FDA approvals of 8 new AML treatments challenges clinicians to select the best regimens for their patients. Eunice S. Wang, MD, provides expert guidance on the best strategies to optimize individualized treatment for patients with AML.

Released: February 12, 2019

Expiration: February 11, 2020

No longer available for credit.

Share

Faculty

Eunice S. Wang

Eunice S. Wang, MD

Chief, Leukemia/Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Celgene

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals Inc

Faculty Disclosure

Primary Author

Eunice S. Wang, MD

Chief, Leukemia/Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York